Ginkgo Bioworks (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and ...

Ginkgo Bioworks promoted its chief accounting officer, Steven Coen, to its top finance role. Coen will succeed Mark Dmytruk, who intends to resign from his role at the biotech company on May 30 to ...

If you want to know who really controls Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), then you'll have to look at the makeup of its share registry. With 56% stake, institutions possess the maximum shares ...

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of ...

Twist Bioscience (NASDAQ:TWST) and Ginkgo Bioworks (NYSE:DNA) said on Thursday that they have updated a previous agreement ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BOSTON, April 29, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it ...

2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the first ...